BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37034033)

  • 1. Tocilizumab in a Child with Acute Leukoencephalopathy with Restricted Diffusion.
    Jaiswal A; Patel S; Khare S; Passi GR
    Ann Indian Acad Neurol; 2023; 26(1):95-96. PubMed ID: 37034033
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute Leucoencephalopathy with Restricted Diffusion in Children - A case series.
    Kamate M; Detroja M; Hattiholi V
    Neurol India; 2021; 69(2):466-469. PubMed ID: 33904477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Leukoencephalopathy with Restricted Diffusion.
    Kamate M
    Indian J Crit Care Med; 2018 Jul; 22(7):519-523. PubMed ID: 30111927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-induced Leukoencephalopathy without Typical Restricted Diffusion on Diffusion-weighted Imaging and the Utility of Magnetic Resonance Spectroscopy to Support the Diagnosis.
    Doan N; Patel M; Nguyen HS; Doan H; Shabani S; Gelsomino M; Mountoure A; Janich K; Chitambar CR
    Asian J Neurosurg; 2018; 13(3):848-850. PubMed ID: 30283563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venom-Induced Reversible Leukoencephalopathy: A Novel Cause of Toxic Acute Leukoencephalopathy With Restricted Diffusion.
    Kamate M; Basavanagowda T; Hattiholi V
    Pediatr Neurol; 2023 Apr; 141():77-78. PubMed ID: 36774684
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA).
    Kobayashi K; Okamoto Y; Inoue H; Usui T; Ihara M; Kawamata J; Miki Y; Mimori T; Tomimoto H; Takahashi R
    Intern Med; 2009; 48(15):1307-9. PubMed ID: 19652436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Multifocal Leukoencephalopathy during Tocilizumab Treatment for Rheumatoid Arthritis.
    Anada M; Tohyama M; Oda Y; Kamoshima Y; Amino I; Nakano F; Miyazaki Y; Akimoto S; Minami N; Kikuchi S; Terae S; Niino M
    Intern Med; 2020 Aug; 59(16):2053-2059. PubMed ID: 32448834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of acute leukoencephalopathy with restricted diffusion (ALERD): A case series and review of literature.
    Lawrence RM; Aripirala P; Reddy N; Rizwan AS; Reddy B S; Poddutoor P; Jain R; Kundana PK; Lingappa L; Konanki R
    Eur J Paediatr Neurol; 2021 Jul; 33():86-93. PubMed ID: 34116345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging.
    McKinney AM; Kieffer SA; Paylor RT; SantaCruz KS; Kendi A; Lucato L
    AJR Am J Roentgenol; 2009 Jul; 193(1):192-206. PubMed ID: 19542414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-Related Leukoencephalopathy: Unusual MRI Features and Comparability to Delayed Post Hypoxic Ischemic Encephalopathy.
    Ahmed M; Gaba WH; Khan FM; Mansoori RA; Adi AAK
    Radiol Case Rep; 2022 Mar; 17(3):852-855. PubMed ID: 35013689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Acute Toxic Leukoencephalopathy: Prediction of the Clinical Outcome by FLAIR and DWI for Various Etiologies.
    Ozturk K; Rykken J; McKinney AM
    AJNR Am J Neuroradiol; 2020 Aug; 41(8):1517-1524. PubMed ID: 32616577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Sabin ND; Cheung YT; Reddick WE; Bhojwani D; Liu W; Glass JO; Brinkman TM; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1919-1925. PubMed ID: 30213807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion weighted imaging in heroin-associated spongiform leukoencephalopathy.
    Bega DS; McDaniel LM; Jhaveri MD; Lee VH
    Neurocrit Care; 2009; 10(3):352-4. PubMed ID: 19116698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxins in Brain! Magnetic Resonance (MR) Imaging of Toxic Leukoencephalopathy - A Pictorial Essay.
    Kumar Y; Drumsta D; Mangla M; Gupta N; Hooda K; Almast J; Mangla R
    Pol J Radiol; 2017; 82():311-319. PubMed ID: 28656068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients.
    Godi C; De Vita E; Tombetti E; Davagnanam I; Haddow L; Jäger HR
    Eur Radiol; 2017 Sep; 27(9):3593-3599. PubMed ID: 28168372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion.
    Dichgans M; Pütz B; Boos D; Auer DP
    AJNR Am J Neuroradiol; 2003; 24(6):1083-9. PubMed ID: 12812930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging phenotypes of CSF1R-related leukoencephalopathy: Systematic review, meta-analysis, and imaging recommendations.
    Mickeviciute GC; Valiuskyte M; Plattén M; Wszolek ZK; Andersen O; Danylaité Karrenbauer V; Ineichen BV; Granberg T
    J Intern Med; 2022 Mar; 291(3):269-282. PubMed ID: 34875121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus Induced Leukoencephalopathy and Stroke-Like Symptoms: Case Report.
    Dopke KM; El Seblani N; Mercer K; Naik S; Mainali G; Paul D
    Child Neurol Open; 2023; 10():2329048X231171011. PubMed ID: 37101431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6-Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy.
    Asano T; Iguchi A; Miyasho T
    J Interferon Cytokine Res; 2020 Jul; 40(7):341-348. PubMed ID: 32614271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.